Order Article Reprints

Perona-Moratalla AB, Carrión B, Villar Gómez de las Heras K, Arias-Salazar L, Yélamos-Sanz B, Segura T, Serrano-Heras G. Dual Inhibition of HIF-1α and HIF-2α as a Promising Treatment for VHL-Associated Hemangioblastomas: A Pilot Study Using Patient-Derived Primary Cell Cultures. Biomedicines. 2025; 13(5):1234. https://doi.org/10.3390/biomedicines13051234

Perona-Moratalla, Ana B., Blanca Carrión, Karina Villar Gómez de las Heras, Lourdes Arias-Salazar, Blanca Yélamos-Sanz, Tomás Segura, and Gemma Serrano-Heras. 2025. "Dual Inhibition of HIF-1α and HIF-2α as a Promising Treatment for VHL-Associated Hemangioblastomas: A Pilot Study Using Patient-Derived Primary Cell Cultures" Biomedicines 13, no. 5: 1234. https://doi.org/10.3390/biomedicines13051234

Perona-Moratalla, A. B., Carrión, B., Villar Gómez de las Heras, K., Arias-Salazar, L., Yélamos-Sanz, B., Segura, T., & Serrano-Heras, G. (2025). Dual Inhibition of HIF-1α and HIF-2α as a Promising Treatment for VHL-Associated Hemangioblastomas: A Pilot Study Using Patient-Derived Primary Cell Cultures. Biomedicines, 13(5), 1234. https://doi.org/10.3390/biomedicines13051234